Drugs that contain Secnidazole
1. Solosec patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11602522 | LUPIN | Secnidazole for use in the treatment of sexually transmitted infection |
Sep, 2035
(11 years from now) | |
| US11000508 | LUPIN | Secnidazole for use in the treatment of trichomoniasis |
Sep, 2035
(11 years from now) | |
| US11324721 | LUPIN | Secnidazole for use in the treatment of trichomoniasis |
Sep, 2035
(11 years from now) | |
| US10335390 | LUPIN | Secnidazole for use in the treatment of bacterial vaginosis |
Sep, 2035
(11 years from now) | |
| US10682338 | LUPIN | Secnidazole for use in the treatment of bacterial vaginosis |
Sep, 2035
(11 years from now) | |
| US10857133 | LUPIN | Secnidazole for use in the treatment of bacterial vaginosis |
Sep, 2035
(11 years from now) | |
| US11000507 | LUPIN | Secnidazole for use in the treatment of bacterial vaginosis |
Sep, 2035
(11 years from now) | |
| US10849884 | LUPIN | Secnidazole for use in the treatment of bacterial vaginosis |
Sep, 2035
(11 years from now) | |
| US11020377 | LUPIN | Secnidazole for use in the treatment of bacterial vaginosis |
Sep, 2035
(11 years from now) | |
| US11684607 | LUPIN | Secnidazole for use in the treatment of bacterial vaginosis |
Sep, 2035
(11 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Chemical Entity Exclusivity(NCE) | Sep 15, 2022 |
| New Indication(I-866) | Jun 30, 2024 |
| New Patient Population(NPP) | Jan 26, 2025 |
| Generating Antibiotic Incentives Now(GAIN) | Sep 15, 2027 |
NCE-1 date: 15 September, 2026
Market Authorisation Date: 15 September, 2017
Treatment: Treatment of trichomoniasis in patients 12 years of age and older; Treatment of bacterial vaginosis in adult women; Treatment of bacterial vaginosis in female patients 12 years of age and older
Dosage: GRANULE;ORAL
More Information on Dosage
SOLOSEC family patents
